Home›Trial›NCT07276581
🔬NCT07276581Phase 2RECRUITING

A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

Study Summary

Phase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163.

Conditions
Rheumatoid Arthritis
Interventions / Drugs
AZD1163Placebo
View on ClinicalTrials.gov ↗
Sponsor
AZN
AstraZeneca
Oncology/Respiratory
F15/100
Study Details
Enrollment320 participants
Primary Completion—
Lead SponsorAstraZeneca
Data Retrieved2026-04-11 02:55:19.909960+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.